DE69508700D1 - Aminosäurederivat mit Anti-CCK-Aktivität - Google Patents

Aminosäurederivat mit Anti-CCK-Aktivität

Info

Publication number
DE69508700D1
DE69508700D1 DE69508700T DE69508700T DE69508700D1 DE 69508700 D1 DE69508700 D1 DE 69508700D1 DE 69508700 T DE69508700 T DE 69508700T DE 69508700 T DE69508700 T DE 69508700T DE 69508700 D1 DE69508700 D1 DE 69508700D1
Authority
DE
Germany
Prior art keywords
amino acid
acid derivative
cck activity
cck
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69508700T
Other languages
English (en)
Other versions
DE69508700T2 (de
Inventor
Masashi Ogawa
Tadashi Morita
Kiyoshi Matsuda
Norihiro Iibuchi
Shinpei Kidokoro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tobishi Pharmaceutical Co Ltd
Original Assignee
Tobishi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6286138A external-priority patent/JP2796944B2/ja
Priority claimed from JP33377694A external-priority patent/JPH08176144A/ja
Application filed by Tobishi Pharmaceutical Co Ltd filed Critical Tobishi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69508700D1 publication Critical patent/DE69508700D1/de
Publication of DE69508700T2 publication Critical patent/DE69508700T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
DE69508700T 1994-10-27 1995-08-11 Aminosäurederivat mit Anti-CCK-Aktivität Expired - Fee Related DE69508700T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6286138A JP2796944B2 (ja) 1994-10-27 1994-10-27 抗cck活性を有するセリン誘導体
JP33377694A JPH08176144A (ja) 1994-12-19 1994-12-19 抗cck活性を有するセリン、アスパラギン酸及びグルタミン酸誘導体

Publications (2)

Publication Number Publication Date
DE69508700D1 true DE69508700D1 (de) 1999-05-06
DE69508700T2 DE69508700T2 (de) 1999-08-05

Family

ID=26556184

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69508700T Expired - Fee Related DE69508700T2 (de) 1994-10-27 1995-08-11 Aminosäurederivat mit Anti-CCK-Aktivität

Country Status (4)

Country Link
US (1) US5716958A (de)
EP (1) EP0710661B1 (de)
CN (1) CN1056842C (de)
DE (1) DE69508700T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801175A (en) * 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
TWI245035B (en) * 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
JP4337138B2 (ja) * 2001-08-31 2009-09-30 味の素株式会社 新規ジアリールアルケン誘導体及び新規ジアリールアルカン誘導体
EP2024364A1 (de) * 2006-05-26 2009-02-18 Neuromed Pharmaceuticals, Ltd. Heterocyclische verbindungen als calciumkanalblocker

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57892B1 (en) * 1984-06-25 1993-05-05 Rotta Research Lab Glutamic and aspartic acid derivatives
IT1215169B (it) 1985-12-17 1990-01-31 Rotta Research Lab Derivati alchil ossigenati degli acidi glutammico ed aspartico ad attivita antagonista su polipeptidi bioattivi e procedimento per la loro preparazione
GB8620060D0 (en) * 1986-08-18 1986-10-01 Roussel Lab Ltd Chemical compounds
US5162231A (en) * 1989-10-25 1992-11-10 Cole Dean A Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung
IT1196849B (it) * 1986-12-16 1988-11-25 Rotta Research Lab Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
IT1217123B (it) * 1987-02-05 1990-03-14 Rotta Research Lab Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
US4971978A (en) * 1987-09-21 1990-11-20 Nadzan Alex M Derivatives of D-glutamic acid and D-aspartic acid
US5346907A (en) * 1988-04-05 1994-09-13 Abbott Laboratories Amino acid analog CCK antagonists
IL91361A (en) 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them
US5248679A (en) * 1988-09-09 1993-09-28 Fujisawa Pharmaceutical Co., Ltd. Tricyclic compounds
FR2643371B1 (fr) * 1989-02-17 1993-11-05 Roussel Uclaf Nouveaux derives de l'acide 2-amino pentanedioique, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
US5716958A (en) 1998-02-10
EP0710661B1 (de) 1999-03-31
EP0710661A1 (de) 1996-05-08
CN1121515A (zh) 1996-05-01
CN1056842C (zh) 2000-09-27
DE69508700T2 (de) 1999-08-05

Similar Documents

Publication Publication Date Title
ATE259349T1 (de) Neue aminosäurederivate mit verbesserter multidrogenresistenz-aktivität
NO920417D0 (no) Aminosyrederivater
NO892407L (no) Aminosyrederivater.
DE69703385T2 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
NO901399D0 (no) Aminosyrederivater.
FI953837A (fi) Synteettisiä aktivoituvia aminohappoja
NO903832D0 (no) Aminosyrederivater.
NO901033D0 (no) Aminosyrederivater.
NO950477D0 (no) Aminosyrederivater
DE69606053D1 (de) Modifizierte fluorsulfonsäure
ATE230734T1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
NO901533D0 (no) Aminosyrederivater.
NO912537D0 (no) Aminosyrederivater.
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
DE69309901D1 (de) Aminosäurederivate mit anticholecystokininwirkung
DE69508700D1 (de) Aminosäurederivat mit Anti-CCK-Aktivität
NO901519D0 (no) Aminosyrederivater.
NO924423L (no) Aminosyrederivater
KR950029623U (ko) 동물모형 조립구
SE9502487D0 (sv) New amino acid derivatives
SE9503923D0 (sv) New amino acid derivatives
SE9504349D0 (sv) New amino acid derivatives
SE9502505D0 (sv) New amino acid derivatives
SE9502504D0 (sv) New amino acid derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee